Skip to main content
Clinical Trials/JPRN-UMIN000004066
JPRN-UMIN000004066CompletedPhase 1

Dose escalation study of intensity-modulated radiotherapy (IMRT) for ipsilateral intrathoracic recurrence after pneumonectomy (lung cancer/mediastinal tumor) or mesothelioma after extrapleural pneumonectomy - Dose escalation study of intensity-modulated radiotherapy (IMRT) for thoracic malignancy after pneumonectomy (TOMO-0801)

Department of Radiation Oncology, Gunma University Graduate School of Medicine0 sites9 target enrollmentStarted: August 23, 2010Last updated:
Conditions

Trial Snapshot

Phase
Phase 1
Status
Completed
Sponsor
Enrollment
9

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to 75years-old (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1) Patient with severe or uncontrolled systemic disease? 2) Patient with systemic active infection 3) Patient who is in pregnancy, lactating, or with a possibility of the pregnancy 4) Patient who is diagnosed with interstitial pneumonia or lung fibrosis by chest CT 5) Patient with severe heart disease (e.g. heart failure requiring medication, myocardial infarction/unstable angina pectoris within the past 3 months, uncontrolled arrhythmia) 6) Patient who is judged inappropriate for the entry into the study by the investigator

Investigators

Sponsor
Department of Radiation Oncology, Gunma University Graduate School of Medicine

Similar Trials